+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1lk3 | ||||||
---|---|---|---|---|---|---|---|
タイトル | ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT | ||||||
![]() |
| ||||||
![]() | IMMUNE SYSTEM / ANTIGEN-ANTIBODY COMPLEX | ||||||
機能・相同性 | ![]() Classical antibody-mediated complement activation / FCGR activation / Regulation of Complement cascade / negative regulation of chronic inflammatory response to antigenic stimulus / interleukin-10 receptor binding / regulation of response to wounding / negative regulation of cytokine activity / Role of phospholipids in phagocytosis / negative regulation of interleukin-18 production / negative regulation of myeloid dendritic cell activation ...Classical antibody-mediated complement activation / FCGR activation / Regulation of Complement cascade / negative regulation of chronic inflammatory response to antigenic stimulus / interleukin-10 receptor binding / regulation of response to wounding / negative regulation of cytokine activity / Role of phospholipids in phagocytosis / negative regulation of interleukin-18 production / negative regulation of myeloid dendritic cell activation / Initial triggering of complement / negative regulation of interferon-alpha production / negative regulation of chemokine (C-C motif) ligand 5 production / response to carbon monoxide / positive regulation of plasma cell differentiation / positive regulation of B cell apoptotic process / Regulation of actin dynamics for phagocytic cup formation / chronic inflammatory response to antigenic stimulus / response to inactivity / cytoplasmic sequestering of NF-kappaB / negative regulation of membrane protein ectodomain proteolysis / regulation of isotype switching / negative regulation of heterotypic cell-cell adhesion / negative regulation of cytokine production involved in immune response / negative regulation of interleukin-1 production / positive regulation of B cell activation / negative regulation of MHC class II biosynthetic process / branching involved in labyrinthine layer morphogenesis / negative regulation of interleukin-8 production / negative regulation of nitric oxide biosynthetic process / phagocytosis, recognition / negative regulation of interleukin-12 production / type 2 immune response / negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway / endothelial cell apoptotic process / positive regulation of MHC class II biosynthetic process / positive regulation of macrophage activation / leukocyte chemotaxis / positive regulation of heterotypic cell-cell adhesion / positive regulation of signaling receptor activity / CD163 mediating an anti-inflammatory response / negative regulation of cytokine production / positive regulation of immunoglobulin production / cellular response to hepatocyte growth factor stimulus / phagocytosis, engulfment / regulation of synapse organization / positive regulation of sprouting angiogenesis / B cell proliferation / negative regulation of B cell proliferation / defense response to protozoan / negative regulation of vascular associated smooth muscle cell proliferation / Interleukin-10 signaling / negative regulation of interleukin-6 production / hemopoiesis / negative regulation of type II interferon production / negative regulation of tumor necrosis factor production / negative regulation of mitotic cell cycle / positive regulation of cell cycle / negative regulation of T cell proliferation / response to glucocorticoid / immunoglobulin complex, circulating / positive regulation of vascular associated smooth muscle cell proliferation / immunoglobulin receptor binding / positive regulation of endothelial cell proliferation / Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation / negative regulation of autophagy / B cell differentiation / FCGR3A-mediated IL10 synthesis / response to activity / positive regulation of cytokine production / cytokine activity / complement activation, classical pathway / cellular response to estradiol stimulus / liver regeneration / antigen binding / B cell receptor signaling pathway / positive regulation of receptor signaling pathway via JAK-STAT / growth factor activity / response to insulin / response to molecule of bacterial origin / positive regulation of DNA-binding transcription factor activity / positive regulation of miRNA transcription / negative regulation of inflammatory response / Signaling by ALK fusions and activated point mutants / regulation of gene expression / cellular response to lipopolysaccharide / Interleukin-4 and Interleukin-13 signaling / protein dimerization activity / defense response to bacterium / response to xenobiotic stimulus / negative regulation of cell population proliferation / external side of plasma membrane / innate immune response / negative regulation of apoptotic process / positive regulation of DNA-templated transcription / positive regulation of transcription by RNA polymerase II / extracellular space / extracellular region 類似検索 - 分子機能 | ||||||
生物種 | ![]() ![]() ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Josephson, K. / Jones, B.C. / Walter, L.J. / DiGiacomo, R. / Indelicato, S.R. / Walter, M.R. | ||||||
![]() | ![]() タイトル: Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography. 著者: Josephson, K. / Jones, B.C. / Walter, L.J. / DiGiacomo, R. / Indelicato, S.R. / Walter, M.R. #1: ![]() タイトル: Design and Analysis of an Engineered Human Interleukin-10 Monomer 著者: Josephson, K. / DiGiacomo, R. / Indelicato, S.R. / Iyo, A.H. / Nagabhushan, T.L. / Parker, M.H. / Walter, M.R. / Ayo, A.H. | ||||||
履歴 |
| ||||||
Remark 999 | SEQUENCE USING BLAST NO APPROPRIATE SEQUENCE DATABASE MATCH WAS FOUND FOR 9D7 LIGHT CHAIN, CHAINS ...SEQUENCE USING BLAST NO APPROPRIATE SEQUENCE DATABASE MATCH WAS FOUND FOR 9D7 LIGHT CHAIN, CHAINS L,M AND 9D7 HEAVY CHAIN, CHAINS H,I. |
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 251.3 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 207.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
文書・要旨 | ![]() | 473 KB | 表示 | ![]() |
---|---|---|---|---|
文書・詳細版 | ![]() | 494.5 KB | 表示 | |
XML形式データ | ![]() | 55 KB | 表示 | |
CIF形式データ | ![]() | 82.5 KB | 表示 | |
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
関連構造データ | |
---|---|
類似構造データ |
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
2 | ![]()
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 18520.324 Da / 分子数: 2 / 断片: Residues 26-175 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() #2: 抗体 | 分子量: 22794.438 Da / 分子数: 2 / 断片: Fab fragment, Residues 1-210 / 由来タイプ: 天然 / 詳細: Hybridoma / 由来: (天然) ![]() ![]() #3: 抗体 | 分子量: 23529.443 Da / 分子数: 2 / 断片: Fab fragment, Residues 1-219 / 由来タイプ: 天然 / 詳細: Hybridoma / 由来: (天然) ![]() ![]() #4: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.67 Å3/Da / 溶媒含有率: 54.01 % | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 298 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 4.6 詳細: peg 4000, sodium citrate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 298K | ||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 4 ℃ / 手法: 蒸気拡散法 | ||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 100 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | タイプ: MARRESEARCH / 検出器: IMAGE PLATE / 日付: 1999年11月20日 |
放射 | モノクロメーター: Si(311) bent monochromator (horizontal focusing) プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.98 Å / 相対比: 1 |
反射 | 解像度: 1.91→50 Å / Num. all: 96708 / Num. obs: 96708 / % possible obs: 91 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3.7 / 冗長度: 3.7 % / Biso Wilson estimate: 23.11 Å2 / Rsym value: 0.049 / Net I/σ(I): 10.5 |
反射 シェル | 解像度: 1.91→1.95 Å / Mean I/σ(I) obs: 1.9 / Rsym value: 0.34 / % possible all: 72.6 |
反射 | *PLUS 最低解像度: 50 Å / Num. measured all: 357669 / Rmerge(I) obs: 0.049 |
反射 シェル | *PLUS % possible obs: 72.6 % / Rmerge(I) obs: 0.34 |
-
解析
ソフトウェア |
| ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]()
| ||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 1.91→50 Å
| ||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||
精密化 | *PLUS 最低解像度: 50 Å | ||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||
原子変位パラメータ | *PLUS |